ONeill DCruz - Cyberonics Insider

Cyberonics Inc -- USA Stock  

USD 69.95  0.83  1.2%

Chief Medical Officer

Dr. ONeill F. DCruz M.D. is Chief Medical Officer of the Company. Dr. DCruz was most recently Medical Director Neurology at UCB S.A. and previously Professor of Neurology and Pediatrics at University of North CarolinaChapel Hill. He also earned a MBA at the KenanFlagler Business School UNCChapel Hill. In addition to industry experience in clinical development pharmacovigilance regulatory interactions publicprivate partnerships and business development Dr. DCruz has worked in the field of epilepsy for over two decades as a boardcertified neurologist and epileptologist health policy and patient advocate clinical investigator and consultant to leading pharmaceutical companies. Dr. DCruz was an investigator in Cyberonics E05 study the pivotal study used to obtain the company original PMA approval for the VNS Therapy System in 1997 as well as in clinical studies of most of the currentlymarketed secondgeneration antiepileptic drugs.
  Executive Since 2014      

Management Efficiency

The company has return on total asset (ROA) of 0.19 % which means that it generated profit of $0.19 on every $100 spent on asset. This is way below average.
The company currently holds 4 K in liabilities with Debt to Equity (D/E) ratio of 0.04 which may suggest the company is not taking enough advantage from borrowing. Cyberonics Inc has Current Ratio of 7.11 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Entity Summary

Cyberonics, Inc., together with its subsidiaries, designs, develops, markets, and sells medical devices to hospitals and ambulatory surgery centers. Cyberonics Inc (CYBX) is traded on NASDAQ in USA. It is located in TEXAS, U.S.A and employs 660 people. Cyberonics is listed under Medical Equipment category by Fama And French industry classification.

Did you try this?

Run Correlation Analysis Now

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Hide  View All  NextLaunch Correlation Analysis
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Cyberonics Inc to your portfolio

Top Management

Cyberonics Inc Leadership Team
Jon Tremmel, Director
Joseph Laptewicz, Director
Daniel Moore, CEO
Alfred Novak, Director
Arthur Rosenthal, Director, MBA
Sherrie Perkins, President
David Wise, SVP
Guy Jackson, Director
Mark Verratti, President
Rohan Hoare, COO
Randal Simpson, President
Gregory Browne, CFO
Darren Alch, VP
Bruce KenKnight, VP
Bryan Olin, President, Ph.D
Hugh Morrison, Chairman
ONeill DCruz, Executive

Stock Performance

Cyberonics Performance Indicators